← Home / ResMed Inc. (RMD)
Stock Analysis
ResMed Inc. (RMD)
RMD
RMD · Market data
220.34 -1.84%
Track RMD in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when RMD price is:
52W Range Position
34%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-08-18 06:22 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 226.51. Holding above 205.35 keeps the current thesis intact.
⚖️
Fundamentals
Improving / Strong
Price Structure
Mixed
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
Hold Above
Structure remains valid above support.
205.35
Break Above
Confirmation improves above resistance.
226.51
🎯
Next Objective
Pattern-derived target if setup continues.
254.61
×
Thesis Break
Scenario weakens below invalidation.
Below 205.35
Recent Company Events
SEC VERIFIED
Latest material filings
AUG
17
Management / Board
MEDIUM
RMD board and management update
On August 13, 2026, Ronald Taylor, a director of Resmed, informed the Board that he will not stand for election at Resmed’s 2026 annual meeting of stockholders (the “Annual Meeting”) and intends to retire from the Board, effective at the Annual Meeting, which is expected to be held on November 18, 2026.
8-K Filing SEC EDGAR
AUG
6
Financial Results
HIGH
RMD reports financial results
On August 6, 2026, we announced that our board of directors declared a quarterly cash dividend of US $0.66 per share, representing an increase of 10% over the previous quarterly dividend.
8-K Filing SEC EDGAR
AUG
6
$
Dividend
HIGH
RMD dividend update
On August 6, 2026, we announced that our board of directors declared a quarterly cash dividend of US $0.66 per share, representing an increase of 10% over the previous quarterly dividend.
8-K Filing SEC EDGAR
What's Driving RMD?
📈 Technical recovery is improving
Momentum is Neutral. Watch 226.51 for confirmation and 205.35 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 205.35 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Technical Setup Active
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Downtrend Structure
Downtrend breakout active · 1 bars old · score 98
Trigger
215.73
First Resistance
222.43
Target
254.61
Invalidation
211.36
DT Break
fresh (age 1)
How to read this setup
The nearest decision zone is framed by support around 205.35 and resistance near 226.51. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
Price Chart
RMD — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-08-17
Quality
Quality premium
The stock trades with a premium profile supported by profitability and quality metrics.
Market Cap
$32.0B
Company size
EV
$31.0B
Debt-adjusted value
P/E
21.0
Reasonable
P/S
5.8
Balanced
P/B
4.9
Balanced
EV/Sales
5.6
Balanced
EV/EBIT
16.4
Low multiple
P/FCF
15.3
Low multiple
FCF Yield
6.55%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Strong financial quality
Growth, profitability, cash flow and balance sheet quality remain broadly supportive.
Revenue Growth
Improving
Profitability
Strong
Cash Flow
Healthy
Balance Sheet
Strong
💵 Revenue
1.43B
↗ Improving
📈 Net Income
398.73M
↗ Strong
🧮 EPS (Basic)
2.74
↗ Strong
ResMed Inc.